{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:14:00Z","timestamp":1793222040709,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jcmg.2020.07.042","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T23:18:26Z","timestamp":1603927106000},"page":"393-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis\/Stiffness in Nondiabetic Heart\u00a0Failure"],"prefix":"10.1016","volume":"14","author":[{"given":"Carlos G.","family":"Santos-Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Requena-Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"San Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Garcia-Ropero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotake","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Picatoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana P.","family":"Vargas-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J.","family":"Flores-Umanzor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2020.07.042_bib1","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial\u00a0energetics","volume":"73","author":"Santos-Gallego","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2020.07.042_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcmg.2018.10.038","article-title":"Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography","volume":"13","author":"Nagueh","year":"2020","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.07.042_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/hrt.2008.159020","article-title":"Evolution and outcome of diastolic dysfunction","volume":"95","author":"Achong","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2020.07.042_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archinternmed.2011.244","article-title":"Mortality rate in patients with diastolic dysfunction and normal systolic function","volume":"171","author":"Halley","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcmg.2020.07.042_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.111.066423","article-title":"Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction","volume":"125","author":"Aljaroudi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2020.07.042_bib8","first-page":"808","article-title":"Diastolic determinants of excess mortality in heart failure with reduced ejection fraction","volume":"7","author":"Benfari","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jcmg.2020.07.042_bib9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ehjci\/jez082","article-title":"Clinical utility of the 2016 ASE\/EACVI recommendations for the evaluation of left ventricular diastolic function in the stratification of post-discharge prognosis in patients with acute heart failure","volume":"20","author":"Machino-Ohtsuka","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.07.042_bib10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.CIR.95.5.1222","article-title":"Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure","volume":"95","author":"Pozzoli","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0735-1097(94)90553-3","article-title":"Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure","volume":"24","author":"Xie","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cardfail.2007.01.010","article-title":"Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis","volume":"13","author":"Somaratne","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jcmg.2020.07.042_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0735-1097(96)00539-6","article-title":"Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign","volume":"29","author":"Pinamonti","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib14","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0735-1097(97)00369-0","article-title":"Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study","volume":"30","author":"Nijland","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.CIR.0000117405.74491.D2","article-title":"Mechanisms of exercise intolerance: insights from tissue Doppler imaging","volume":"109","author":"Skaluba","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2020.07.042_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10557-018-6786-x","article-title":"Do the SGLT-2 inhibitors offer more than hypoglycemic activity?","volume":"32","author":"Flores","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jcmg.2020.07.042_bib19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/17425255.2018.1551877","article-title":"The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments","volume":"14","author":"Garcia-Ropero","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.115.012427","article-title":"Sphingosine-1-phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia\/reperfusion","volume":"133","author":"Santos-Gallego","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2020.07.042_bib22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jacc.2009.06.030","article-title":"Abnormal\u00a0regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning","volume":"54","author":"Ishii","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCIMAGING.109.879304","article-title":"Automated segmentation of routine clinical cardiac magnetic resonance imaging for assessment of left ventricular diastolic dysfunction","volume":"2","author":"Kawaji","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.07.042_bib24","doi-asserted-by":"crossref","first-page":"H1423","DOI":"10.1152\/ajpheart.01211.2011","article-title":"Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP\/dt (max) complementary or redundant?","volume":"302","author":"Ishikawa","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib25","doi-asserted-by":"crossref","first-page":"H1478","DOI":"10.1152\/ajpheart.00797.2013","article-title":"Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions","volume":"307","author":"Ishikawa","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib26","article-title":"Increased stiffness is the major early abnormality in a pig model of severe aortic stenosis and predisposes to congestive heart failure in the absence of systolic dysfunction","volume":"4","author":"Ishikawa","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2020.07.042_bib27","first-page":"312","article-title":"Myocardial Microvascular Inflammatory Endothelial Activation in Heart\u00a0Failure With Preserved Ejection Fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jcmg.2020.07.042_bib28","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0735-1097(02)02921-2","article-title":"Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value","volume":"41","author":"Wang","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.07.042_bib29","first-page":"27","article-title":"Empagliflozin improves diastolic function in a nondiabetic rodent model of heart failure with preserved ejection fraction","volume":"4","author":"Connelly","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jcmg.2020.07.042_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10557-017-6734-1","article-title":"Empagliflozin improves left ventricular diastolic dysfunction in a genetic model of type 2 diabetes","volume":"31","author":"Hammoudi","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jcmg.2020.07.042_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc19-2187","article-title":"Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure: the REFORM trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcmg.2020.07.042_bib32","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and\u00a0reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2020.07.042_bib33","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","article-title":"Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality","volume":"126","author":"Wong","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib34","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCRESAHA.108.193326","article-title":"Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium","volume":"104","author":"Borbely","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jcmg.2020.07.042_bib35","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","article-title":"Role of left ventricular stiffness in heart failure with normal ejection fraction","volume":"117","author":"Westermann","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.07.042_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-018-06850-0","article-title":"Rationale and design of the EMPA-TROPISM trial (ATRU-4): are the \u201ccardiac benefits\u201d of empagliflozin independent of its hypoglycemic activity?","volume":"33","author":"Santos-Gallego","year":"2019","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X20307993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X20307993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:50:31Z","timestamp":1761846631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X20307993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1936878X20307993"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2020.07.042","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis\/Stiffness in Nondiabetic Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2020.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}